» Articles » PMID: 23028920

NOTCH1, HIF1A and Other Cancer-related Proteins in Lung Tissue from Uranium Miners--variation by Occupational Exposure and Subtype of Lung Cancer

Overview
Journal PLoS One
Date 2012 Oct 3
PMID 23028920
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Radon and arsenic are established pulmonary carcinogens. We investigated the association of cumulative exposure to these carcinogens with NOTCH1, HIF1A and other cancer-specific proteins in lung tissue from uranium miners.

Methodology/principal Findings: Paraffin-embedded tissue of 147 miners was randomly selected from an autopsy repository by type of lung tissue, comprising adenocarcinoma (AdCa), squamous cell carcinoma (SqCC), small cell lung cancer (SCLC), and cancer-free tissue. Within each stratum, we additionally stratified by low or high level of exposure to radon or arsenic. Lifetime exposure to radon and arsenic was estimated using a quantitative job-exposure matrix developed for uranium mining. For 22 cancer-related proteins, immunohistochemical scores were calculated from the intensity and percentage of stained cells. We explored the associations of these scores with cumulative exposure to radon and arsenic with Spearman rank correlation coefficients (r(s)). Occupational exposure was associated with an up-regulation of NOTCH1 (radon r(s) = 0.18, 95% CI 0.02-0.33; arsenic: r(s) = 0.23, 95% CI 0.07-0.38). Moreover, we investigated whether these cancer-related proteins can classify lung cancer using supervised and unsupervised classification. MUC1 classified lung cancer from cancer-free tissue with a failure rate of 2.1%. A two-protein signature discriminated SCLC (HIF1A low), AdCa (NKX2-1 high), and SqCC (NKX2-1 low) with a failure rate of 8.4%.

Conclusions/significance: These results suggest that the radiation-sensitive protein NOTCH1 can be up-regulated in lung tissue from uranium miners by level of exposure to pulmonary carcinogens. We evaluated a three-protein signature consisting of a physiological protein (MUC1), a cancer-specific protein (HIF1A), and a lineage-specific protein (NKX2-1) that could discriminate lung cancer and its major subtypes with a low failure rate.

Citing Articles

Transcriptomic analysis reveals transcription factors implicated in radon-induced lung carcinogenesis.

Liu X, Peng Y, Chen R, Zhou Y, Zou X, Xia M Toxicol Res (Camb). 2024; 13(5):tfae161.

PMID: 39371682 PMC: 11447380. DOI: 10.1093/toxres/tfae161.


Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-Stage Lung Cancer Diagnosis.

Wan L, Liu Q, Liang D, Guo Y, Liu G, Ren J Front Oncol. 2021; 11:630672.

PMID: 34136379 PMC: 8202280. DOI: 10.3389/fonc.2021.630672.


Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population.

Aguilar-Madrid G, Pesch B, Calderon-Aranda E, Burek K, Jimenez-Ramirez C, Juarez-Perez C Int J Med Sci. 2018; 15(9):883-891.

PMID: 30008600 PMC: 6036095. DOI: 10.7150/ijms.23939.


gene rs10873142 polymorphism is associated with risk of chronic obstructive pulmonary disease in a Chinese Han population: a case-control study.

Wang L, Tang Y, Chen Y Biosci Rep. 2018; 38(2).

PMID: 29339421 PMC: 5843754. DOI: 10.1042/BSR20171309.


Impact of multiple Alcohol Dehydrogenase gene polymorphisms on risk of laryngeal, esophageal, gastric and colorectal cancers in Chinese Han population.

An J, Zhao J, Zhang X, Ding R, Geng T, Feng T Am J Cancer Res. 2015; 5(8):2508-15.

PMID: 26396927 PMC: 4568787.


References
1.
Semenza G . Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003; 3(10):721-32. DOI: 10.1038/nrc1187. View

2.
Maeda Y, Dave V, Whitsett J . Transcriptional control of lung morphogenesis. Physiol Rev. 2007; 87(1):219-44. DOI: 10.1152/physrev.00028.2006. View

3.
Williams O, Sharafkhaneh A, Kim V, Dickey B, Evans C . Airway mucus: From production to secretion. Am J Respir Cell Mol Biol. 2006; 34(5):527-36. PMC: 2644218. DOI: 10.1165/rcmb.2005-0436SF. View

4.
Luo W, Semenza G . Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells. Oncotarget. 2011; 2(7):551-6. PMC: 3248177. DOI: 10.18632/oncotarget.299. View

5.
Blair A, Stewart P, Lubin J, Forastiere F . Methodological issues regarding confounding and exposure misclassification in epidemiological studies of occupational exposures. Am J Ind Med. 2006; 50(3):199-207. DOI: 10.1002/ajim.20281. View